Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02411318Completed
Open-label trial (5 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Change in Neutrophil Chemotactic Velocity. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02411318.